Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 707

1.

Increased risk of thiopurine-related adverse events in elderly patients with IBD.

Calafat M, Mañosa M, Cañete F, Ricart E, Iglesias E, Calvo M, Rodríguez-Moranta F, Taxonera C, Nos P, Mesonero F, Martín-Arranz MD, Mínguez M, Gisbert JP, García-López S, de Francisco R, Gomollón F, Calvet X, Garcia-Planella E, Rivero M, Martínez-Cadilla J, Argüelles F, Arias L, Cimavilla M, Zabana Y, Domènech E; ENEIDA registry of GETECCU.

Aliment Pharmacol Ther. 2019 Aug 19. doi: 10.1111/apt.15458. [Epub ahead of print]

PMID:
31429097
2.

Protocol of the European Registry on the management of Helicobacter pylori infection (Hp-EuReg).

McNicholl AG, O'Morain CA, Megraud F, Gisbert JP; As Scientific Committee of the Hp-Eureg on Behalf of the National Coordinators.

Helicobacter. 2019 Jul 8:e12630. doi: 10.1111/hel.12630. [Epub ahead of print]

PMID:
31282060
3.

Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry.

Iborra M, Beltrán B, Fernández-Clotet A, Gutiérrez A, Antolín B, Huguet JM, De Francisco R, Merino O, Carpio D, García-López S, Mesonero F, Navarro P, Ferreiro-Iglesias R, Carbajo AY, Rivero M, Gisbert JP, Piñero-Pérez MC, Monfort D, Bujanda L, García-Sepulcre MF, Martín-Cardona A, Cañete F, Taxonera C, Domènech E, Nos P; GETECCU Group (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa).

Aliment Pharmacol Ther. 2019 Aug;50(3):278-288. doi: 10.1111/apt.15371. Epub 2019 Jun 20.

PMID:
31222872
4.

EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.

Chaparro M, Barreiro-de Acosta M, Benítez JM, Cabriada JL, Casanova MJ, Ceballos D, Esteve M, Fernández H, Ginard D, Gomollón F, Lorente R, Nos P, Riestra S, Rivero M, Robledo P, Rodríguez C, Sicilia B, Torrella E, Garre A, García-Esquinas E, Rodríguez-Artalejo F, Gisbert JP; EpidemIBD study group of GETECCU.

Therap Adv Gastroenterol. 2019 May 21;12:1756284819847034. doi: 10.1177/1756284819847034. eCollection 2019.

5.

Warnings on the safety of quinolones: Should Helicobacter pylori treatment prescriptions be modified?

McNicholl AG, Gisbert JP.

Gastroenterol Hepatol. 2019 Aug - Sep;42(7):461-463. doi: 10.1016/j.gastrohep.2019.03.008. Epub 2019 May 19. English, Spanish. No abstract available.

PMID:
31113653
6.

Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions.

McNicholl AG, Amador J, Ricote M, Cañones-Garzón PJ, Gene E, Calvet X, Gisbert JP; Spanish Primary Care Societies SEMFyC; SEMERGEN and SEMG, the Spanish Association of Gastroenterology; OPTICARE Long-Term Educational Project.

Helicobacter. 2019 Aug;24(4):e12593. doi: 10.1111/hel.12593. Epub 2019 May 20.

PMID:
31111627
7.

Efficacy of tofacitinib treatment in ulcerative colitis.

Panés J, Gisbert JP.

Gastroenterol Hepatol. 2019 Jun - Jul;42(6):403-412. doi: 10.1016/j.gastrohep.2019.03.002. Epub 2019 May 14. Review. English, Spanish.

8.

Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers.

Mañosa M, Chaparro M, Juan A, Aràjol C, Alfaro I, Mínguez M, Velayos B, Benítez JM, Mesonero F, Sicilia B, Zabana Y, Villoria A, Gisbert JP, Domènech E; ENEIDA registry by GETECCU.

Am J Gastroenterol. 2019 May;114(5):771-776. doi: 10.14309/ajg.0000000000000210.

PMID:
31082839
9.

Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.

Guerra I, Bujanda L, Castro J, Merino O, Tosca J, Camps B, Gutiérrez A, Gordillo Ábalos J, de Castro L, Iborra M, Carbajo AY, Taxonera C, Rodríguez-Lago I, Mesonero F, de Francisco R, Gómez-Gómez GJ, Chaparro M, Tardillo CA, Rivero M, Algaba A, Martín Arranz E, Cañete F, Vicente R, Sicilia B, Antolín B, Prieto V, Márquez L, Benítez JM, Camo P, Piqueras M, Gargallo CJ, Hinojosa E, Huguet JM, Pérez Calle JL, Van Domselaar M, Rodriguez C, Calvet X, Muñoz-Villafranca C, García-Sepulcre MF, Munoz-Garrido P, Fernández-Clotet A, Gómez Irwin L, Hernández S, Guardiola J, Sempere L, González Muñoza C, Hernández V, Beltrán B, Barrio J, Alba C, Moraleja I, López-Sanromán A, Riestra S, Martínez Montiel P, Garre A, Arranz L, García MJ, Martín Arranz MD, Corsino P, Arias L, Fernández-Salazar L, Fernández-Pordomingo A, Andreu M, Iglesias E, Ber Y, Mena R, Arroyo Villarino MT, Mora M, Ruiz L, López-Serrano P, Blazquez I, Villoria A, Fernández M, Bermejo F, Banales JM, Domènech E, Gisbert JP; Spanish GETECCU group (ENEIDA Project).

J Crohns Colitis. 2019 May 7. pii: jjz094. doi: 10.1093/ecco-jcc/jjz094. [Epub ahead of print]

PMID:
31063540
10.

Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn's disease.

Aterido A, Palau N, Domènech E, Nos Mateu P, Gutiérrez A, Gomollón F, Mendoza JL, Garcia-Planella E, Barreiro-de Acosta M, Muñoz F, Vera M, Saro C, Esteve M, Andreu M, Chaparro M, Panés J, García-Sánchez V, López-Lasanta M, Pluma A, Codó L, García-Montero A, Manyé J, Gisbert JP, Marsal S, Julià A.

Pharmacogenomics J. 2019 May 2. doi: 10.1038/s41397-019-0090-4. [Epub ahead of print]

PMID:
31043678
11.

Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.

Cañete F, Mañosa M, Casanova MJ, González-Sueyro RC, Barrio J, Bermejo F, Nos P, Iglesias-Flores E, García-Planella E, Pérez-Calle JL, Vicente R, Vera M, Ramos L, Rivero M, De Francisco R, Montserrat A, Benítez O, Navarro P, Taxonera C, Hinojosa E, Márquez-Mosquera L, Navarro-Llavat M, Ramírez-de la Piscina P, Gomollón F, Rodríguez-Alonso L, Núñez-Alonso A, Fernández-Salazar L, Almela P, Ríos León R, De Castro L, Gisbert JP, Ricart E, Cabré E, Domènech E; ENEIDA registry by GETECCU.

Inflamm Bowel Dis. 2019 Apr 22. pii: izz084. doi: 10.1093/ibd/izz084. [Epub ahead of print]

PMID:
31006801
12.

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients.

McNicholl AG, Bordin DS, Lucendo A, Fadeenko G, Fernandez MC, Voynovan I, Zakharova NV, Sarsenbaeva AS, Bujanda L, Perez-Aisa Á, Vologzhanina L, Zaytsev O, Ilchishina T, Coba C, Lasala JP, Alekseenko S, Modolell I, Molina-Infante J, Ruiz-Zorrilla Lopez R, Alonso-Galan H, Moreno NF, Hinojosa J, Santaella I, Varela P, Gonzalez-Cordero PL, Barrio J, Dominguez-Jimenez JL, Nuñez O, Alcedo J, Nyssen OP, Caldas M, Donday MG, Shvetz O, Megraud F, O'Morain C, Gisbert JP.

Clin Gastroenterol Hepatol. 2019 Apr 10. pii: S1542-3565(19)30369-6. doi: 10.1016/j.cgh.2019.03.048. [Epub ahead of print]

PMID:
30978536
13.

Effectiveness and safety of the switch from Remicade to CT-P13 in patients with inflammatory bowel disease.

Chaparro M, Garre A, Guerra Veloz MF, Vázquez JM, De Castro ML, Leo E, Rodriguez E, Carbajo AY, Riestra S, Jiménez I, Calvet X, Bujanda L, Rivero M, Gomollón F, Benítez JM, Bermejo F, Alcaide N, Gutiérrez A, Mañosa M, Iborra M, Lorente R, Rojas-Feria M, Barreiro-de Acosta M, Kolle L, Van Domselaar M, Amo V, Argüelles F, Ramírez E, Morell A, Bernardo D, Gisbert JP.

J Crohns Colitis. 2019 Apr 12. pii: jjz070. doi: 10.1093/ecco-jcc/jjz070. [Epub ahead of print]

PMID:
30976785
14.

Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pylori.

Nyssen OP, McNicholl AG, Gisbert JP.

Helicobacter. 2019 Apr;24(2):e12570. doi: 10.1111/hel.12570. Epub 2019 Feb 14.

PMID:
30767339
15.

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus.

Danese S, Allez M, van Bodegraven AA, Dotan I, Gisbert JP, Hart A, Lakatos PL, Magro F, Peyrin-Biroulet L, Schreiber S, Tarabar D, Vavricka S, Halfvarson J, Vermeire S.

Dig Dis. 2019;37(4):266-283. doi: 10.1159/000496739. Epub 2019 Feb 6.

16.

Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study.

Chavarría C, Casanova MJ, Chaparro M, Barreiro-de Acosta M, Ezquiaga E, Bujanda L, Rivero M, Argüelles-Arias F, Martín-Arranz MD, Martínez-Montiel MP, Valls M, Ferreiro-Iglesias R, Llaó J, Moraleja-Yudego I, Casellas F, Antolín-Melero B, Cortés X, Plaza R, Pineda JR, Navarro-Llavat M, García-López S, Robledo-Andrés P, Marín-Jiménez I, García-Sánchez V, Merino O, Algaba A, Arribas-López MR, Banales JM, Castro B, Castro-Laria L, Honrubia R, Almela P, Gisbert JP.

J Crohns Colitis. 2019 Aug 14;13(8):996-1002. doi: 10.1093/ecco-jcc/jjz024.

PMID:
30721954
17.

Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial.

Taxonera C, López-Sanromán A, Vera-Mendoza I, Domènech E, Ruiz VV, Marín-Jiménez I, Guardiola J, Castro L, Esteve M, Iglesias E, Ceballos D, Martínez-Montiel P, Gisbert JP, Mínguez M, Echarri A, Calvet X, Barrio J, Hinojosa J, Martín-Arranz MD, Márquez-Mosquera L, Bermejo F, Rimola J, Alba C, Pons V, Nos P; Spanish GETECCU group (APPRECIA study).

Dig Liver Dis. 2019 Apr;51(4):529-535. doi: 10.1016/j.dld.2019.01.002. Epub 2019 Jan 14.

PMID:
30712954
18.

Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity.

Martínez-López M, Iborra S, Conde-Garrosa R, Mastrangelo A, Danne C, Mann ER, Reid DM, Gaboriau-Routhiau V, Chaparro M, Lorenzo MP, Minnerup L, Saz-Leal P, Slack E, Kemp B, Gisbert JP, Dzionek A, Robinson MJ, Rupérez FJ, Cerf-Bensussan N, Brown GD, Bernardo D, LeibundGut-Landmann S, Sancho D.

Immunity. 2019 Feb 19;50(2):446-461.e9. doi: 10.1016/j.immuni.2018.12.020. Epub 2019 Jan 29.

19.

European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in Russia.

Bordin DS, Embutnieks YV, Vologzhanina LG, Il'chishina TA, Voinovan IN, Sarsenbaeva AS, Alekseenko SA, Zaitsev OV, Abdulkhakov RA, Osipenko MF, Livzan MA, Tsukanov VV, Burkov SG, Bakulina NV, Dekhnich NN, Tarasova LV, Plotnikova EY, Maev IV, Kucheryavyi YA, Baryshnikova NV, Butov MA, Kolbasnikov SV, Pakhomova AL, Zhestkova TV, Baranovskii AY, Abdulkhakov SR, Ageeva EA, Lyalyukova EA, Vasyutin AV, Golubev NN, Savilova IV, Morkovkina LV, Kononova AG, Megraud F, O'Morain C, Ramas M, Nyssen OP, McNicholl AG, Gisbert JP.

Ter Arkh. 2018 Feb 15;90(2):35-42. doi: 10.26442/terarkh201890235-42.

PMID:
30701770
20.

Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unit.

Alvaro-Gracia JM, Arredondo M, Daudén E, Meca-Lallana V, Morell A, Gisbert JP, Fernández-Jiménez G, García de Vicuña R, Aspa FJ, García de Yébenes MJ, Carmona L.

Reumatol Clin. 2019 Mar - Apr;15(2):63-68. doi: 10.1016/j.reuma.2018.11.008. Epub 2019 Jan 26. English, Spanish.

21.

Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU.

Chaparro M, Garre A, Ricart E, Iglesias-Flores E, Taxonera C, Domènech E, Gisbert JP; ENEIDA study group.

Aliment Pharmacol Ther. 2019 Feb;49(4):419-428. doi: 10.1111/apt.15114. Epub 2019 Jan 13.

PMID:
30637837
22.

Systematic review with meta-analysis: the prevalence of bile acid malabsorption and response to colestyramine in patients with chronic watery diarrhoea and previous cholecystectomy.

Ruiz-Campos L, Gisbert JP, Ysamat M, Arau B, Loras C, Esteve M, Fernández-Bañares F.

Aliment Pharmacol Ther. 2019 Feb;49(3):242-250. doi: 10.1111/apt.15099. Epub 2018 Dec 25. Review.

PMID:
30585336
23.

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.

Chaparro M, Barreiro-de Acosta M, Echarri A, Almendros R, Barrio J, Llao J, Gomollón F, Vera M, Cabriada JL, Guardiola J, Guerra I, Beltrán B, Roncero O, Busquets D, Taxonera C, Calvet X, Ferreiro-Iglesias R, Ollero Pena V, Bernardo D, Donday MG, Garre A, Godino A, Díaz A, Gisbert JP.

Dig Dis Sci. 2019 Mar;64(3):846-854. doi: 10.1007/s10620-018-5362-3. Epub 2018 Nov 13.

PMID:
30426297
24.

'Quality of Care' Standards in Inflammatory Bowel Disease: A Systematic Review.

Fiorino G, Allocca M, Chaparro M, Coenen S, Fidalgo C, Younge L, Gisbert JP.

J Crohns Colitis. 2019 Jan 1;13(1):127-137. doi: 10.1093/ecco-jcc/jjy140.

PMID:
30423033
25.

Pregnancy and Inflammatory Bowel Disease: A Long Way to Go.

Chaparro M, Gisbert JP.

Am J Gastroenterol. 2018 Dec;113(12):1903-1904. doi: 10.1038/s41395-018-0379-y. Epub 2018 Oct 24. No abstract available.

PMID:
30356179
26.

Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive Review.

Gisbert JP, Chaparro M.

J Crohns Colitis. 2019 Mar 26;13(3):374-384. doi: 10.1093/ecco-jcc/jjy158. Review.

PMID:
30307487
27.

Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey.

Rodríguez-Lago I, Ferreiro-Iglesias R, Nos P, Gisbert JP; en representación del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU).

Gastroenterol Hepatol. 2019 Feb;42(2):90-101. doi: 10.1016/j.gastrohep.2018.09.002. Epub 2018 Oct 4. English, Spanish.

PMID:
30293913
28.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease.

Guardiola J, Lobatón T, Cerrillo E, Ferreiro-Iglesias R, Gisbert JP, Domènech E, Chaparro M, Esteve M, Rodríguez-Moranta F; en representación de GETECCU.

Gastroenterol Hepatol. 2018 Oct;41(8):514-529. doi: 10.1016/j.gastrohep.2018.05.029. Epub 2018 Jul 4. English, Spanish.

29.

Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.

Chaparro M, Garre A, Ricart E, Iborra M, Mesonero F, Vera I, Riestra S, García-Sánchez V, Luisa De Castro M, Martin-Cardona A, Aldeguer X, Mínguez M, de-Acosta MB, Rivero M, Muñoz F, Andreu M, Bargalló A, González-Muñoza C, Pérez Calle JL, García-Sepulcre MF, Bermejo F, Huguet JM, Cabriada JL, Gutiérrez A, Mañosa M, Villoria A, Carbajo AY, Lorente R, García-López S, Piqueras M, Hinojosa E, Arajol C, Sicilia B, Conesa AM, Sainz E, Almela P, Llaó J, Roncero O, Camo P, Taxonera C, Domselaar MV, Pajares R, Legido J, Madrigal R, Lucendo AJ, Alcaín G, Doménech E, Gisbert JP; GETECCU study group.

Aliment Pharmacol Ther. 2018 Oct;48(8):839-851. doi: 10.1111/apt.14930.

PMID:
30281832
30.

Treatment of Helicobacter pylori infection in 2018.

O'Morain NR, Dore MP, O'Connor AJP, Gisbert JP, O'Morain CA.

Helicobacter. 2018 Sep;23 Suppl 1:e12519. doi: 10.1111/hel.12519. Review.

PMID:
30203585
31.

Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14.

Companioni O, Bonet C, García N, Ramírez-Lázaro MJ, Lario S, Mendoza J, Adrados MM, Poves E, Espinosa L, Pozo-Kreilinger JJ, Ortega L, Bujanda L, Cosme A, Ferrández A, Muñoz G, Cuatrecasas M, Elizalde I, Andreu V, Paules MJ, Madrigal B, Barrio J, Berdasco M, Calvet X, Sanz-Anquela JM, Gisbert JP, González CA, Sala N; Study Group.

Int J Cancer. 2018 Dec 1;143(11):2777-2786. doi: 10.1002/ijc.31839. Epub 2018 Oct 4.

PMID:
30171605
32.

Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial.

McNicholl AG, Molina-Infante J, Lucendo AJ, Calleja JL, Pérez-Aisa Á, Modolell I, Aldeguer X, Calafat M, Comino L, Ramas M, Callejo Á, Badiola C, Serra J, Gisbert JP.

Helicobacter. 2018 Oct;23(5):e12529. doi: 10.1111/hel.12529. Epub 2018 Aug 23.

PMID:
30141228
33.

Acute severe ulcerative colitis: State of the art treatment.

Gisbert JP, Chaparro M.

Best Pract Res Clin Gastroenterol. 2018 Feb - Apr;32-33:59-69. doi: 10.1016/j.bpg.2018.05.007. Epub 2018 May 12. Review.

PMID:
30060940
34.

Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease.

Taxonera C, Ponferrada Á, Riestra S, Bermejo F, Saro C, Martín-Arranz MD, Cabriada JL, Barreiro-de Acosta M, de Castro ML, López-Serrano P, Barrio J, Suarez C, Iglesias E, Argüelles-Arias F, Ferrer I, Marín-Jiménez I, Hernández-Camba A, Bastida G, Van Domselaar M, Martínez-Montiel P, Olivares D, Rivero M, Fernandez-Salazar L, Nantes Ó, Merino O, Alba C, Gisbert JP; CONVERT study group from GETECCU .

J Crohns Colitis. 2018 Nov 15;12(11):1270-1279. doi: 10.1093/ecco-jcc/jjy104.

PMID:
30052856
35.

The Innate Immune System in the Gastrointestinal Tract: Role of Intraepithelial Lymphocytes and Lamina Propria Innate Lymphoid Cells in Intestinal Inflammation.

Montalban-Arques A, Chaparro M, Gisbert JP, Bernardo D.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1649-1659. doi: 10.1093/ibd/izy177. Review.

PMID:
29788271
36.

Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review.

Gisbert JP, Chaparro M.

Gastroenterol Hepatol. 2018 Jun - Jul;41(6):389-405. doi: 10.1016/j.gastrohep.2018.04.005. Epub 2018 May 9. English, Spanish.

37.

Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease.

Bernardo D, Marin AC, Fernández-Tomé S, Montalban-Arques A, Carrasco A, Tristán E, Ortega-Moreno L, Mora-Gutiérrez I, Díaz-Guerra A, Caminero-Fernández R, Miranda P, Casals F, Caldas M, Jiménez M, Casabona S, De la Morena F, Esteve M, Santander C, Chaparro M, Gisbert JP.

Mucosal Immunol. 2018 Jul;11(4):1114-1126. doi: 10.1038/s41385-018-0030-7. Epub 2018 May 9.

PMID:
29743615
38.

Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.

Ordás I, Domènech E, Mañosa M, García-Sánchez V, Iglesias-Flores E, Rodríguez-Moranta F, Márquez L, Merino O, Fernández-Bañares F, Gomollón F, Vera M, Gutiérrez A, LLaó J, Gisbert JP, Aguas M, Arias L, Rodríguez-Lago I, Muñoz C, Alcaide N, Calvet X, Rodríguez C, Montoro MA, García S, De Castro ML, Piqueras M, Pareja L, Ribes J, Panés J, Esteve M; ENEIDA registry of GETECCU.

Am J Gastroenterol. 2018 Jul;113(7):1009-1016. doi: 10.1038/s41395-018-0057-0. Epub 2018 May 1.

PMID:
29713028
39.

Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study.

Molina-Infante J, Gutierrez-Junquera C, Savarino E, Penagini R, Modolell I, Bartolo O, Prieto-García A, Mauro A, Alcedo J, Perelló A, Guarner-Argente C, Alcaide N, Vegas AM, Barros-García P, Murzi-Pulgar M, Perona M, Gisbert JP, Lucendo AJ; Upper GI Tract Study Group from the Spanish Gastroenterological Association (AEG).

Am J Gastroenterol. 2018 Jul;113(7):972-979. doi: 10.1038/s41395-018-0035-6. Epub 2018 Mar 15.

PMID:
29545632
40.

Helicobacter Pylori Treatment Results in Slovenia in the Period 2013-2015 as a Part of European Registry on Helicobacter Pylori Management.

Tepes B, Kastelic M, Vujasinovic M, Lampic P, Seruga M, Jurecic NB, Nyssen OP, Donday MG, O'Morain C, Megraud F, McNicholl AG, Gisbert JP.

Radiol Oncol. 2017 Dec 7;52(1):1-6. doi: 10.1515/raon-2017-0055. eCollection 2018 Mar.

41.

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.

Chaparro M, Verreth A, Lobaton T, Gravito-Soares E, Julsgaard M, Savarino E, Magro F, Biron AI, Lopez-Serrano P, Casanova MJ, Gompertz M, Vitor S, Arroyo M, Pugliese D, Zabana Y, Vicente R, Aguas M, Shitrit BA, Gutierrez A, Doherty GA, Fernandez-Salazar L, Cadilla MJ, Huguet JM, OʼToole A, Stasi E, Marcos MN, Villoria A, Karmiris K, Rahier JF, Rodriguez C, Palomares DM, Fiorino G, Benitez JM, Principi M, Naftali T, Taxonera C, Mantzaris G, Sebkova L, Iade B, Lissner D, Bradley FI, Roman LA, Marin-Jimenez I, Merino O, Sierra M, Van Domselaar M, Caprioli F, Guerra I, Peixe P, Piqueras M, Rodriguez-Lago I, Ber Y, van Hoeve K, Torres P, Gravito-Soares M, Rudbeck-Resdal D, Bartolo O, Peixoto A, Martin G, Armuzzi A, Garre A, Donday MG, de Carpi MFJ, Gisbert JP.

Am J Gastroenterol. 2018 Mar;113(3):396-403. doi: 10.1038/ajg.2017.501. Epub 2018 Feb 20.

PMID:
29460920
42.

Update on the management of Helicobacter pylori infection. Position paper from the Catalan Society of Digestology.

Sánchez Delgado J, García-Iglesias P, Titó L, Puig I, Planella M, Gené E, Saló J, Martínez-Cerezo F, Molina-Infante J, Gisbert JP, Calvet X.

Gastroenterol Hepatol. 2018 Apr;41(4):272-280. doi: 10.1016/j.gastrohep.2017.12.009. Epub 2018 Feb 6. English, Spanish.

PMID:
29426621
43.

Validation of the 'United Registries for Clinical Assessment and Research' [UR-CARE], a European Online Registry for Clinical Care and Research in Inflammatory Bowel Disease.

Burisch J, Gisbert JP, Siegmund B, Bettenworth D, Thomsen SB, Cleynen I, Cremer A, Ding NJS, Furfaro F, Galanopoulos M, Grunert PC, Hanzel J, Ivanovski TK, Krustins E, Noor N, O'Morain N, Rodríguez-Lago I, Scharl M, Tua J, Uzzan M, Ali Yassin N, Baert F, Langholz E.

J Crohns Colitis. 2018 Apr 27;12(5):532-537. doi: 10.1093/ecco-jcc/jjy015.

PMID:
29415255
44.

Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.

Jusué V, Chaparro M, Gisbert JP.

Dig Liver Dis. 2018 Apr;50(4):353-359. doi: 10.1016/j.dld.2017.12.022. Epub 2017 Dec 30.

PMID:
29396129
45.

Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study.

Mañosa M, Calafat M, de Francisco R, García C, Casanova MJ, Huelín P, Calvo M, Tosca J, Fernández-Salazar L, Arajol C, Zabana Y, Bastida G, Hinojosa J, Márquez L, Barreiro-de-Acosta M, Calvet X, Monfort D, Gómez-Garcia MR, Rodríguez E, Huguet JM, Rojas-Feria M, Hervias D, Atienza R, Busquets D, Zapata E, Dueñas C, Charro M, Martínez-Cerezo FJ, Plaza R, Vázquez JM, Gisbert JP, Cañete F, Cabré E, Domènech E; GETECCU.

Aliment Pharmacol Ther. 2018 Mar;47(5):605-614. doi: 10.1111/apt.14494. Epub 2018 Jan 25.

46.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease.

Bermejo F, Aguas M, Chaparro M, Domènech E, Echarri A, García-Planella E, Guerra I, Gisbert JP, López-Sanromán A; en representación de GETECCU.

Gastroenterol Hepatol. 2018 Mar;41(3):205-221. doi: 10.1016/j.gastrohep.2017.11.007. Epub 2018 Jan 19. Review. English, Spanish.

PMID:
29357999
47.

Human Intestinal Dendritic Cells in Inflammatory Bowel Diseases.

Bernardo D, Chaparro M, Gisbert JP.

Mol Nutr Food Res. 2018 Apr;62(7):e1700931. doi: 10.1002/mnfr.201700931. Epub 2018 Mar 1. Review.

PMID:
29336524
48.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.

Barreiro-de Acosta M, Marín-Jiménez I, Panadero A, Guardiola J, Cañas M, Gobbo Montoya M, Modino Y, Alcaín G, Bosca-Watts MM, Calvet X, Casellas F, Chaparro M, Fernández Salazar L, Ferreiro-Iglesias R, Ginard D, Iborra M, Manceñido N, Mañosa M, Merino O, Rivero M, Roncero O, Sempere L, Vega P, Zabana Y, Mínguez M, Nos P, Gisbert JP.

Gastroenterol Hepatol. 2018 Feb;41(2):118-127. doi: 10.1016/j.gastrohep.2017.10.003. Epub 2017 Dec 21. English, Spanish.

PMID:
29275001
49.

Corrigendum: Research to the N-Power: The Strengths of Networked Clinical Collaboration in Spain.

McNicholl AG, Gisbert JP.

Am J Gastroenterol. 2018 Feb;113(2):311. doi: 10.1038/ajg.2017.476. Epub 2017 Dec 19.

PMID:
29257144
50.

Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.

Garcia-Planella E, Mañosa M, Chaparro M, Beltrán B, Barreiro-de-Acosta M, Gordillo J, Ricart E, Bermejo F, García-Sánchez V, Piqueras M, Llaó J, Gisbert JP, Cabré E, Domènech E; PRECUCAL study group Investigators.

Scand J Gastroenterol. 2018 Feb;53(2):152-157. doi: 10.1080/00365521.2017.1410219. Epub 2017 Nov 30.

PMID:
29189092

Supplemental Content

Loading ...
Support Center